Compare Monster Beverage Corp (MNST) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Monster Beverage Corp vs Health Care Select Sector SPDR Fund — how do they compare? Monster Beverage Corp trades at $42.85 (market cap $83.93B), while Health Care Select Sector SPDR Fund trades at $167.13. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Monster Beverage Corp nearer its low. Which is the better fit depends on your goals.
| MNST | XLV | |
|---|---|---|
Market Cap | $83.93B | — |
Sector | Consumer Staples | — |
52-Week High | $49.97 | $175.68 |
52-Week Low | $31.41 | $134.13 |
Enterprise Value | $82.22B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Monster Beverage (MNST) trades at $43.15, down 1.53% on the day, following a recent 2-for-1 stock split completed in August 2026. The stock exhibits a bullish technical signal from oscillators despite bearish moving averages, with key support at $42. Fundamentally, the company reported strong Q2 2026 earnings, beating estimates with $0.30 EPS, and shows robust revenue growth, with 2025 revenue reaching $8.29 billion and net income of $1.91 billion. Profitability remains high, with a net margin of 23.08% and ROE of 25.7%.
The outlook for MNST is positive, driven by consistent earnings beats, international expansion accounting for 46% of sales, and analyst consensus favoring a buy rating with a $51.10 price target. Key risks include elevated valuation multiples, such as a P/E of 39.95, and competitive pressures in the energy drink sector. Investors should weigh growth prospects against premium pricing.
XLV trades at $167.16, down 2.5% amid testing key support levels, with technical indicators showing mixed signals between bullish moving averages and bearish oscillators. The healthcare ETF maintains defensive appeal with upcoming dividend payments and sector rotation benefits during potential Fed tightening. Recent options activity shows increased put volume, suggesting some near-term caution among traders.
Healthcare sector strength and defensive positioning support XLV's long-term outlook, though near-term technical weakness and sector-specific headwinds from failed drug trials present risks. The ETF's low expense ratio and diversified healthcare exposure provide stability, with earnings momentum and FDA approvals driving fundamental strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Monster Beverage Corp
Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
